コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and transcription regulation (INSIG1, PPARG, PPARGC1A).
2 ctivated receptor gamma coactivator 1-alpha (Ppargc1a).
3 a coactivator 1alpha (PGC-1alpha, encoded by Ppargc1a).
4 and had a parallel pattern of expression to PPARGC1A.
5 prostaglandin signaling and cooperation with Ppargc1a.
6 ogenesis and known to interact with PPARs or PPARGC1A.
7 vity and combinatorial binding patterns with PPARGC1A.
8 PARG G allele (rs1801282) and noncarriers of PPARGC1A A allele (rs8192678) had 21 and 13% lower hepat
9 ceptor gamma-coactivator 1alpha; also called PPARGC1A) a coactivator of the Kdm5a target genes, is su
10 ctivated receptor gamma coactivator 1-alpha (PPARGC1A), a coactivator of the transcription factor PPA
11 in PPAR gamma (PPARG) co-activator 1 alpha (PPARGC1A), a gene encoding a co-activator of the LCPUFA-
12 ctivated receptor-gamma coactivator-1 alpha (PPARGC1A), a master transcriptional regulator of mitocho
14 ARGC1a (also known as PGC-1alpha; encoded by Ppargc1a), a transcriptional coactivator that regulates
20 related positively with expression levels of PPARGC1A and CDK4 and negatively with expression levels
24 ap of targets including a novel link between PPARGC1A and HSF1, a TF regulating the conserved heat sh
25 tudies have focused on the interplay between PPARGC1A and individual TFs, but little is known about h
26 to 8-br-cAMP with a 200% greater increase in Ppargc1a and Pck1 expression, and a 30% increase in G6pc
27 eta (PGC-1alpha and PGC-1beta, also known as Ppargc1a and Ppargc1b, respectively) and the downstream
29 inhibits, whereas Notch inhibition induces, Ppargc1a and Prdm16 transcription in white adipocytes.
30 epG2 cells were transfected with variants of PPARGC1A and protein and messenger RNA levels were measu
33 tor (MC2R), MC3R, PPARG coactivator 1 alpha (PPARGC1A), and tumor necrosis factor (TNF), was changed
34 ltiple targets such as SIRT3, FOXO1, PRKAA1, PPARGC1A, and CREBBP directly regulate reactive oxygen s
37 50 directly targets and represses Prdm16 and Ppargc1a, and that forced expression of miR-150 attenuat
38 iptional regulators of metabolism, PPARG and PPARGC1A, as well as SCD1, the rate-limiting enzyme for
39 a coactivator-1alpha (PGC-1alpha, encoded by Ppargc1a) by SIRT1 activators, our results illustrate ho
40 their co-activators Pgc1alpha (also known as Ppargc1a), CBP/p300 (Crebbp) and Src1 (Ncoa1) to the PPR
42 ndividual TFs, but little is known about how PPARGC1A combines with all of its partners across the ge
43 ficient hearts, suggesting that up-regulated Ppargc1a confers increased mitochondrial metabolism and
44 s of down-regulated genes (e.g. AMPK, TORC2, PPARGC1A) correspond to a single common pathway importan
46 atment did not affect the heart size of Flcn/Ppargc1a doubly inactivated hearts, further supporting t
50 d is required for the transcription of Ucp1, Ppargc1a (encoding PGC-1alpha), and oxidative phosphoryl
51 of host tolerance to infection involving the Ppargc1a/Esrra axis in its influence on Mpc1/OXPHOS-depe
52 nhibition of HNF-1beta significantly reduced PPARGC1A expression and altered mitochondrial morphology
53 We also demonstrated downregulation of renal PPARGC1A expression in a patient with an HNF1B germinal
59 Increasing physical activity, which induces PPARGC1A expression, is a potential strategy to slow DNA
60 zygous or homozygous disruption of Ppargc1a (Ppargc1a(f/+)Alb-cre(+/0) and Ppargc1a(f/f) Alb-cre(+/0)
61 Oxidative damage was observed in livers from Ppargc1a(f/+)Alb-cre(+/0) mice of each sex, in a cell-au
62 he increased liver damage observed in female Ppargc1a(f/+)Alb-cre(+/0) mice; while, compensatory incr
63 n of Ppargc1a (Ppargc1a(f/+)Alb-cre(+/0) and Ppargc1a(f/f) Alb-cre(+/0) mice, respectively) were fed
65 ne distributions of DNA sequence variants in PPARGC1A for association with NV AMD and interaction of
66 a Tug1-binding element (TBE) upstream of the Ppargc1a gene and showed that Tug1 binds with the TBE to
71 activated receptor gamma coactivator-1alpha (Ppargc1a) gene encodes several PGC-1alpha isoforms that
72 n and examined the relationship between nine PPARGC1A genetic variants, DNA damage, type 2 diabetes,
73 variants showed significant association, and PPARGC1A haplotypes exhibited significant association af
76 deficient hearts and indeed, inactivation of Ppargc1a in Flcn-deficient hearts significantly reduced
77 ir, mice harboring a conditional deletion of Ppargc1a in monocyte-derived macrophages or mice adminis
80 demonstrate the concurrent up-regulation of PPARGC1a in the epithelial compartment and androgen rece
81 activated receptor-gamma coactivator-1alpha (PPARGC1A) in skeletal muscle and subcutaneous adipose ti
88 induced early and transient inflammation and PPARGC1A inhibition, which overlapped with downregulatio
92 sition of resistance to ERBB2 inhibition and PPARGC1A is instrumental in promoting a switch to depend
93 ted hearts, further supporting the idea that Ppargc1a is the critical element leading to deregulation
94 a) coactivator alpha (PGC-1alpha, encoded by Ppargc1a) is functionally regulated by the lncRNA taurin
95 Several functional candidate genes such as PPARGC1A, LDB2 and LCORL were found within or close to t
97 -activated receptor-gamma coactivator-alpha (PPARGC1A) messenger RNA (mRNA) in skin fibroblast cultur
99 Loss of the ROS and mitochondrial control in Ppargc1a(-/-) mice causes the death of paligenotic cells
100 nal ischaemia, Pgc1alpha(-/-) (also known as Ppargc1a(-/-)) mice develop local deficiency of the NAD
101 of starved mice also had increased levels of Ppargc1a mRNA and Creb3l3 mRNA, which encode a transcrip
103 eductions in palmitate- stimulated Cpt1a and Ppargc1a mRNA, ULK1 phosphorylation and autophagic/mitop
106 ses expression of PPARG coactivator 1 alpha (PPARGC1A or PGC1a protein) at the level of transcription
107 d receptor-gamma (PPARG) coactivator 1alpha (PPARGC1A or PGC1A) is inversely correlated with liver fa
110 transcription factor MITF drives PGC1alpha (PPARGC1A) overexpression in a subset of human melanomas
111 chondrial biogenesis and their key regulator Ppargc1a Overnutrition worsened excitotoxicity-induced m
113 fragmentation factor alpha-like effector A), Ppargc1a (Peroxisome Proliferator-Activated Receptor Gam
114 on noncanonical targets, including Nampt and Ppargc1a [peroxisome proliferator-activated receptor-gam
115 the transcriptional mitochondrial regulator Ppargc1a (Pgc1alpha) and ROS regulator Nf2el2 (Nrf2).
116 with liver-specific hemizygous disruption of Ppargc1a placed on an obesogenic diet expressed increase
119 cific hemizygous or homozygous disruption of Ppargc1a (Ppargc1a(f/+)Alb-cre(+/0) and Ppargc1a(f/f) Al
120 ted genes (including the master coactivators Ppargc1a, Ppargc1b, and their downstream targets) and pr
124 GC receptor/DNMT3b complex in binding to the Ppargc1a promoter, potentially driving its de novo DNA m
125 g pregnancy increases DNA methylation in the Ppargc1a promoter, which epigenetically impairs BAT ther
129 ligo patients, whereas its predicted targets PPARGC1A, RRM2, and TAOK1 were reciprocally up-regulated
132 e evaluated the independent influence of the PPARGC1A rs8192678 risk A allele on pediatric NAFLD afte
133 , sex, and PNPLA3 rs738409 polymorphism, the PPARGC1A rs8192678 risk A allele was an independent risk
134 We aimed to test the hypothesis that the PPARGC1A rs8192678 risk A allele would influence the ris
136 mong 9 genes (ADRB3, ENPP1, FTO, LEP, PPARG, PPARGC1A, SLC2A2, TCF7L2, and UCP2) associated with type
137 ed that seven genes (CDKN1A, ESR1, MAX, MYC, PPARGC1A, SP1, and STK11) and one novel MYC-centered pat
138 cription factor (PPARG co-activator 1 alpha, PPARGC1A) to age-related macular degeneration (AMD) and
139 he highest-docked targets, SIRT3, FOXO1, and PPARGC1A, to assess the stability and interactions.
140 r demonstrate that SCF/Kit directly promotes Ppargc1a transcription and mitochondrial biogenesis.
141 This SnapShot summarizes how regulation of Ppargc1a transcription, splicing, translation, protein s
143 ic genes, such as PPAR-gamma coactivator 1a (Ppargc1a), uncoupling protein 1 (Ucp1) and acyl-CoA synt
144 irst mapped the genome-wide binding sites of PPARGC1A using chromatin-IP followed by high-throughput
149 erator-activated receptor gamma cofactor 1A (PPARGC1A) was 1.75-fold reduced with insulin resistance
150 eceptor-gamma coactivator (PGC)-1alpha gene (PPARGC1A) was identified to be associated with nonalcoho
152 R-resident regulatory variant (rs3774923) in PPARGC1A were independently associated with NV AMD (exac
154 tivated receptor gamma, coactivator 1 alpha (Ppargc1a), which acts upstream of Ptgs1-mediated prostag
156 through direct transcriptional induction of PPARGC1a, which in turn activates PPARalpha to upregulat